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Abstract	  Drawing	   on	   fieldwork	   in	   four	   condition	   areas	   (rare	   diseases,	   childbirth,	   Attention	  Deficit	  Hyperactivity	  Disorder,	  and	  Alzheimer’s	  disease),	   this	  article	  shows	  that	  patients’	  organizations’	  (POs)	  engagement	  with	  knowledge	  is	  neither	  limited	  to	  a	  set	  of	  diseases	  nor	  restricted	   to	   biomedical	   knowledge.	   Their	  work	   on	   and	  with	   academic	   and	   experiential	  knowledge	   contributes	   to	   an	   understanding	   of	   their	   conditions	   and	   the	   problems	   they	  induce,	  and	  to	  the	  shaping	  of	  the	  causes	  they	  defend.	  This	  results	  in	  the	  production	  of	  new	  evidence	  for	  grounding	  research	  and	  health	  policies	  in	  their	  condition	  areas.	  The	  authors	  propose	   the	   notion	   of	   “evidence-­‐based	   activism”	   to	   capture	   the	   centrality	   of	   knowledge	  activities	  in	  contemporary	  POs.	  	  
Keywords	  Patients’	  organizations,	  health	  activism,	  evidence-­‐based	  activism,	  healthcare	  policy,	  ADHD,	  Alzheimer,	  rare	  diseases,	  childbirth	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INTRODUCTION	  Over	   the	   past	   decades,	   social	   scientists	   have	   extensively	   studied	   the	   involvement	   of	  patients’	   organizations	   in	   biomedical	   research	   as	   illustrative	   of	   the	   upsurge	   of	   lay	  expertise	  and	  of	  the	  democratization	  of	  science	  and	  technology	  (see	  for	  instance	  Brown	  et	  al.,	  2004;	  Epstein,	  1995;	  Rabeharisoa	  &	  Callon,	  1999).	  Biomedical	  research	  however	  is	  not	  the	   only	   research	   area	   in	   which	   patients’	   organizations	   invest.	   Blume’s	   (2009)	  investigation	   of	   deaf	   communities	   offers	   a	   seminal	   example:	   he	   shows	   that	   rather	   than	  embracing	  a	  biomedical	  framing	  of,	  and	  “solutions”	  to	  deafness,	  these	  communities	  turn	  to	  socio-­‐linguistics	  with	  a	  view	  to	  assert	  sign	  language	  as	  a	  language	  on	  its	  own	  right,	  and	  as	  the	   pivotal	   ingredient	   of	   deaf	   culture.	   His	   and	   other	   studies	   suggest	   that	   patients’	  organizations	   and	   groups	   of	   activists’	   engagement	   with	   certain	   bodies	   of	   knowledge	  should	   be	   examined	   in	   light	   of	   the	   causes	   they	   defend.	   This	   article	   pursues	   this	   line	   of	  reflection:	   it	   looks	  at	  how	  patients’	  organizations	  and	  groups	  of	  activists	   relate	   issues	  of	  knowledge	  to	  their	  politics	  of	  illness,	  and	  how	  this	  (potentially)	  impacts	  on	  the	  structuring	  of	  research	  policies	  on	  their	  conditions.	  We	   draw	   on	   fieldwork	   we	   undertook	   in	   four	   condition	   areas,	   namely	   rare	   diseases,	  ADHD	  (Attention	  Deficit	  Hyperactivity	  Disorder)	  and	  childbirth	  in	  France,	  and	  Alzheimer’s	  disease	   in	   Ireland.	   Considering	   these	   four	   condition	   areas	  was	  motivated	   by	   concerned	  patients’	  organizations	  and	  groups	  of	  activists’	  contrasted	  positioning	  vis-­‐à-­‐vis	  biomedical	  research.	  French	  rare	  diseases	  patients’	  organizations	  massively	  engage	  with	  biomedical	  research	   to	   foster	   the	   development	   of	   cures,	   whereas	   the	   French	   group	   of	   parents	   of	  children	  with	  ADHD	  considers	  biomedical	  knowledge	  as	  one	  body	  of	  knowledge	  amongst	  many	   others	   pursued	   for	   a	   better	   understanding	   of	   the	   disorder.	   The	   French	   group	   of	  childbirth	  activists	  enters	  into	  the	  black	  box	  of	  medical	  evidence	  on	  certain	  birth	  practices	  to	  point	   to	   their	   limits	  and	  reveal	   their	  shadow	  zones,	  whereas	   the	  Alzheimer	  Society	  of	  Ireland	   mobilizes	   social	   sciences	   methodologies	   for	   expressing	   patients’	   views	   and	  reflecting	  on	  patient-­‐centered	  care.	  	  How	   to	  make	   sense	   of	   the	   variety	   of	   knowledge,	   and	   of	   knowledge-­‐related	   activities	  undertaken	  by	  the	  patients’	  organizations	  and	  groups	  of	  activists	  mentioned	  above?	  One	  may	  argue	  that	  the	  conditions	  at	  stake	  and	  the	  national	  contexts	  play	  a	  determinant	  role.	  We	  take	  a	  different	  stance	  here.	  Rather	  than	  positing	  conditions	  and	  national	  contexts	  as	  givens,	   we	   look	   at	   how	   these	   groups	   problematize	   their	   conditions	   and	   picture	   the	  network	   of	   expertise	   and	   issues	   they	   deem	   relevant	   to	   target.	   Indeed,	   our	   fieldwork	  suggests	   that	   clarifying	  what	   their	   conditions	   are,	  what	   they	   are	   the	   cause	   of,	   and	  what	  issues	   should	   be	   addressed	   at	   an	   individual	   and	   a	   collective	   level,	   constitutes	   the	  main	  preoccupation	   of	   these	   groups.	   This	   implies	   a	   radically	   different	   view	  on	   knowledge	   for	  these	   groups	   and	   for	   the	   social	   scientists	   who	   study	   them:	   rather	   than	   contemplating	  knowledge	   as	   a	  mere	   resource	   “out	   there”	   which	   patients’	   organizations	   and	   groups	   of	  activists	   rely	   upon	   for	   defending	   their	   causes,	   knowledge	   (and	   what	   counts	   as	   such),	  should	   be	   considered	   as	   “something”	   to	   be	   produced	   and	   discussed.	   This	   article	   shows	  that	  patients’	  organizations	  and	  groups	  of	  activists	  collect	  and	   format	  concerned	  people’	  experiences	   to	   document	   what	   it	   is	   to	   have/live	   with	   their	   conditions.	   They	  simultaneously	   identify	  pieces	  of	  academic	  knowledge	  on	   their	   conditions,	  and	  weight	   it	  up	  against	   their	   “experiential	  knowledge”	   (Arksey,	  1994;	  Borkman,	  1976).	  This	  work	  on	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and	  with	  academic	  and	  experiential	  knowledge	   contributes	   to	   sorting	  out,	   ordering,	   and	  articulating	   an	   understanding	   of	   their	   conditions	   and	   the	   problems	   they	   induce,	   for	  themselves	   and	   for	   specialists.	   This	   reconfigures	   the	   epistemic	   network	   they	   make	  themselves	   part	   and	   parcel	   of,	   and	   results	   in	   politics	   of	   knowledge	   that	   eventually	  transforms	   the	   modalities	   of	   research,	   and	   in	   the	   production	   of	   new	   evidence	   for	  grounding	   health	   policies	   in	   their	   condition	   areas.	   This	   is	   the	   reason	   why	   we	   suggest	  calling	  this	  form	  of	  patients’	  activism:	  “evidence-­‐based	  activism”	  (Rabeharisoa,	  Moreira	  &	  Akrich,	  2013).	  The	   following	   sections	   of	   this	   article	   document	   and	   analyze	   these	   groups’	   “evidence-­‐based	   activism”,	   and	   the	   compound	   dynamic	   interplay	   between	   politics	   of	   illness	   and	  politics	  of	  knowledge	   it	  entails	   in	  the	   four	  condition	  areas	  we	  studied.	  Section	  1	   looks	  at	  French	   rare	   diseases	   patients’	   organizations’	   engagement	   with	   biomedical	   research.	  Thanks	   to	   a	   better	   understanding	   of	   their	   bio-­‐clinical	   profiles	   and	   improved	   care	  strategies,	  patients	  now	  experience	   the	  extension	  of	   their	   life	  expectancy	  and	  a	  series	  of	  problems	  similar	  to	  those	  with	  which	  patients	  with	  chronic	  illnesses	  are	  familiar.	  So	  much	  so	  that	   these	  organizations	  now	  embrace	  a	  diversified	  range	  of	  knowledge,	  and	  promote	  their	   articulation	   via	   interlinked	   platforms	   associating	   biologists,	   clinicians,	   health	  professionals	   and	   patients’	   groups.	   Section	   2	   on	   ADHD	   looks	   at	   how	   HyperSupers,	   the	  French	  group	  of	  parents,	  strives	  to	  make	  sense	  of	  their	  experience	  of	  the	  complex,	  variable	  and	   individual	   manifestations	   of	   the	   disorder,	   and	   to	   articulate	   a	   multidisciplinary	  network	   of	   expertise	   associating	   neuroscientists,	   geneticists,	   behavioral	   scientists,	   child	  psychiatrists,	   psychologists,	   educational	   scientists,	   and	   pharmacologists,	   on	   this	  confrontational	   condition.	   In	   doing	   so,	   the	   group	   intends	   to	   connect	   different	   scientific	  communities	  around	  ADHD,	  which	  so	  far	  keep	  apart	  from	  each	  other.	  Departing	  from	  the	  classic	  picturing	  of	   childbirth	   activism	  as	   a	   feminist	  movement	   seeking	   to	  de-­‐medicalize	  childbirth	  practices,	  Section	  3	  focuses	  on	  the	  strikingly	  intense	  and	  enduring	  effort	  of	  the	  CIANE,	  the	  French	  group	  of	  childbirth	  activists,	  in	  the	  critical	  reading	  of	  medical	  evidence	  on	  certain	  birth	  practices,	   and	   its	   confrontation	   to	  women’s	  experiences	   they	  draw	  on	  a	  series	   of	   surveys.	   This	   highly	   sophisticated	  work	   on	   and	  with	   various	   species	   of	   figures	  and	  statistics	  questions	  medical	  evidence	   from	  the	   inside,	  as	  much	  as	   it	  challenges,	   from	  the	   outside,	   the	   range	  of	   relevant	   evidence	   on	  what	   “normal	   birth”	   should	  be.	   Section	  4	  looks	  at	  how	   the	  Alzheimer	  Society	  of	   Ireland	   reflect	  on	   the	   relevance	  of	   social	   sciences	  methodologies	   for	   collecting	   and	   expressing	   the	   views	  of	   people	  with	  dementia,	   and	   for	  putting	  them	  center-­‐stage	  in	  the	  provision	  of	  services.	  Rather	  than	  simply	  mobilizing	  these	  methodologies,	   the	   organization’s	   involvement	   in	   mutually	   informing	   politics	   of	   illness,	  politics	  of	  knowledge	  and	  politics	  of	  identity	  has	  required	  it	  to	  renew	  them.	  	  Reflecting	   on	   the	   similarities	   and	   differences	   between	   the	   four	   condition	   areas	   we	  explored,	   the	   concluding	   section	   offers	   a	   few	   thoughts	   on	   whether	   the	   intervention	   of	  patients’	  organizations	  and	  groups	  of	  activists	  in	  the	  fabrics	  of	  knowledge	  entails	  a	  process	  of	   co-­‐optation	   and	   institutionalization	   of	   patients’	   activism.	   Does	   “evidence-­‐based	  activism”	  put	  patients’	  organizations	  and	  groups	  of	  activists	  at	  risk	  of	  loosing	  sight	  of	  their	  identity	  and	  oppositional	  power?	  Though	  we	  should	  avoid	  romanticizing	  “evidence-­‐based	  activism”,	  our	  analysis	  suggests	  that	  it	  brings	  in	  uncertainties	  on	  what	  exactly	  relevant	  and	  legitimate	   evidence	   is,	   and	   therefore	   introduces	   a	   form	   of	   collective	   reflexivity	   on	   the	  shaping	  of	  research	  policies.	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THE	   DUAL	   DYNAMICS	   OF	   RESEARCH	   AND	   ISSUES:	   THE	   TRANSFORMATION	   OF	   RARE	   DISEASES	  
ACTIVISM	  On	   the	   two	   sides	   of	   the	   Atlantic,	   patients’	   activism	   in	   the	   area	   of	   rare	   diseases	   was	  originally	   motivated	   by	   the	   absence	   of	   cures	   for	   these	   lethal	   conditions	   (Asbury	   1985;	  Brewer	  1983;	  Crompton	  2007;	  Huyard	  2011/2).	  In	  France,	  the	  AFM	  (Association	  Française	  
contre	  les	  Myopathies	  –	  French	  Association	  against	  Myopathies),	  created	  in	  1958	  by	  a	  few	  parents	  of	  children	  with	  Duchenne	  de	  Boulogne	  dystrophy,	  has	  played	  a	  prominent	  role	  in	  relating	  this	  deficiency	  of	  the	  drug	  market	  to	  specialists’	  ignorance	  and	  lack	  of	  interest	  in	  these	  diseases	  because	  of	  their	  rareness,	  and	  to	  the	  need	  for	  patients’	  and	  parents’	  groups	  to	  actively	  engage	  with	  biomedical	  research.	  Aimed	  at	  “knowing	  the	  enemy	  [the	  disease]	  for	  combating	  it”,	  as	  the	  former	  President	  of	  the	  AFM	  phrased	  the	  cause	  of	  the	  association,	  it	   articulates	   “therapeutic	   activism”	   (Epstein	   1995)	   to	   “biomedical	   activism”.	   Since	   the	  mid-­‐1980s,	   the	   AFM	   has	   established	   partnerships	   with	   the	   biomedical	   community	  (Rabeharisoa	   2003).	   In	   the	   absence	   of	   a	   robust	   corpus	   of	   credentialed	   knowledge	   on	  neuromuscular	   diseases,	   the	   AFM	   has	   introduced	   families’	   experiences	   to	   biomedical	  practitioners	  with	  a	  view	  to	  start	  and	  sustain	  the	  research	  process	  (Rabeharisoa	  &	  Callon	  2004).	   It	   has	   provided	   financial	   support	   to	   research	   teams,	   and	   has	   participated	   in	   the	  orientation	   of	   research	   policies	   on	   neuromuscular	   and	   other	   rare	   diseases	   in	   France	  through	  its	  annual	  call	  for	  research	  projects	  (Rabeharisoa	  &	  Callon	  1999).	  The	  model	   of	   engagement	  with	   biomedical	   research	   that	   the	   AFM	   has	   promoted	   has	  been	   adopted	   and	   adapted	   by	   a	   number	   of	   French	   rare	   disease	   patients’	   organizations.	  Drawing	   on	   interviews	   and	   ethnographic	   observations	   of	   twelve	   French	   rare	   diseases	  patients’	  organizations,	  all	  created	  after	  the	  AFM	  and	  contrasted	  in	  terms	  of	  their	  size,	  the	  nature	   and	  prevalence	   of	   their	   diseases,	   their	   resources	   and	  organizational	   features,	  we	  observed	   that	   even	   though	   these	   groups	   do	   not	   intervene	   directly	   in	   the	   definition	   and	  conduct	  of	  research	  activities	  as	  the	  AFM	  does,	  they	  nevertheless	  establish	  dialogue	  with	  researchers,	   scrutinize	   research	   hypothesis	   and	   findings,	   and	   circulate	   them	   to	   families	  and	   medical	   and	   health	   professionals.	   When	   asked	   about	   their	   motives	   for	   such	   an	  intensive	   acquisition	   and	   dissemination	   of	   scientific	   knowledge	   and	   enduring	  relationships	   with	   the	   biomedical	   community,	   they	   mention	   a	   series	   of	   interlinked	  problems	  which,	  according	   to	  patients	  and	   families,	   continue	   to	  hinder	   the	   “war	  on	  rare	  diseases”:	   the	   scarcity	   of	   information	   available	   on	   these	   conditions,	   the	   low	  numbers	   of	  clinicians	   who	   can	   accurately	   diagnose	   their	   diseases	   and	   provide	   care	   to	   patients,	   the	  complexity	   of	   rare	   diseases	   and	   the	   need	   for	   longstanding	   investments	   in	   research,	   and	  the	   need	   to	   ensure	   that	   research	   teams	   they	   ally	   with	   explore	   the	   topics	   they	   deem	  important	  for	  a	  better	  understanding	  of	  their	  pathologies.	  As	  patients’	  representatives	  we	  interviewed	  suggested,	  “war	  on	  diseases”	  is	  a	  multifaceted	  endeavor,	  implying	  a	  complex	  investigation	   for	   deciphering	   the	   diseases	   at	   stake	   and	   the	   problems	   they	   come	   with,	  including	   those	   resulting	   from	   the	   perceived	   deficiencies	   of	   the	   market,	   the	   research	  system	   and	   the	   medical	   and	   health	   institutions	   when	   facing	   rare	   diseases.	   This	  problematization	   of	   rare	   diseases	   has	   multiple	   and	   interrelated	   consequences	   on	   the	  research	   policies	   and	   politics	   of	   knowledge	   in	   this	   area.	   Two	   of	   them	   are	   particularly	  worth	  being	  highlighted.	  Firstly,	  for	  a	  number	  of	  rare	  diseases,	  the	  dialogue	  between	  patients’	  organizations	  and	  specialists,	   though	   sometimes	   confrontational,	   gives	   shape	   to	   epistemic	   communities	  
5	  	  
gathering	   patients,	   researchers	   and	   clinicians	   around	   the	   collective	   exploration	   of	  diseases,	  and	  within	  which	  experiential	  knowledge	  and	  academic	  knowledge	  constitutes	  a	  seamless	  web	   of	   knowledge.	   One	   remarkable	   feature	   of	   these	   communities	   is	   that	   their	  contours,	  as	  well	  as	  their	  epistemic	  focus,	  progressively	  evolve	  alongside	  the	  knowledge,	  problems	  and	  issues	  brought	  in	  by	  the	  different	  parties.	  To	  take	  but	  one	  example,	  SolHand	  
Solidarité	   Handicap	   –	   Autour	   des	   Maladies	   Rares	   (Association	   on	   rare	   disabilities	   and	  diseases),	   formed	   in	   2008,	   brings	   to	   the	   fore	   questions	   that	   its	   chairwoman	  qualifies	   as	  “medico-­‐social”	  and	  on	  which	  no	  research	  has	  as	  yet	  been	  undertaken.	  The	  formulation	  of	  these	  questions	   is	  partly	  enabled	  by	  the	  efforts	   that	  have	  been	  devoted	  to	  biological	  and	  clinical	   research.	   The	   results	   obtained	   have	   had	   the	   effect	   not	   of	   healing	   patients	   (cure	  remains	  rare),	  but	  of	  gradually	  adjusting	  the	  care	  they	  receive.	  The	  natural	  history	  of	  rare	  diseases	   has	   thus	   been	   altered.	   Some	   of	   them	   became	   chronic	   illnesses	   that	   generated	  unexpected	  problems,	  on	   the	   fringes	  of	  biomedicine.	  That	   is	  why	  SolHand	   claims	   for	   the	  need	  to	  mobilize	  rehabilitation	  therapists	  and	  researchers	  in	  human	  and	  social	  sciences	  in	  the	  production	  of	  knowledge	  focused	  on	  solutions	  to	  problems	  that	  patients	  encounter	  in	  their	  daily	  lives,	  such	  as	  chronic	  pain,	  fatigue,	  depression,	  disability,	  or	  inclusion	  in	  the	  job	  market.	  Interestingly,	   this	  articulation	  of	  biomedical	   research	   to	   the	  production	  of	  knowledge	  on	  families’	  day-­‐to-­‐day	  preoccupations	  and	  the	  adjustment	  of	  care	  practices	  now	  stands	  at	  the	  core	  of	  research	  and	  public	  policies	  on	  rare	  diseases.	  In	  2000,	  patients’	  organizations	  decided	  to	  coalesce	  within	  the	  French	  Alliance	  on	  Rare	  Diseases	  and	  asked	  for	  the	  creation	  of	  centers	  of	  reference	  for	  diagnosis	  and	  care	  in	  various	  regions	  of	  France.	  This	  resulted	  in	  the	  launching	  of	  a	  National	  Plan	  for	  Rare	  Diseases	  by	  the	  French	  government	  in	  2004,	  and	  the	   creation	   and	   support	   to	   centers	   of	   reference	   which	   propose	   multidisciplinary	  consultations	   and	   assemble	   researchers,	   clinicians,	   and	   care	   professionals,	   for	   ensuring	  the	   continuity	   from	  research	   to	   the	   clinic,	   from	  diagnosis	   to	   treatments,	   social	   care,	   and	  information	   to	   patients	   and	   families.	   How	   exactly	   this	   articulation	   between	   biomedical	  research	   and	   healthcare	   is	   performed,	   and	   to	  what	   extent	   patients’	   organizations	   act	   as	  full-­‐fledged	  stakeholders	  in	  the	  functioning	  of	  these	  centers,	  remain	  to	  be	  explored.	  Suffice	  here	  to	  say	  that	  these	  centers	  design	  innovative	  platforms	  for	  research	  and	  care	  policies,	  within	   which	   a	   variety	   of	   academic	   and	   experiential	   knowledge	   and	   know-­‐how	   are	  supposed	  to	  mutually	  nurture.	  This	  also	  led	  to	  the	  recently	  formed	  French	  Foundation	  on	  Rare	   Diseases,	   responsible	   for	   coordinating	   research	   efforts	   in	   this	   condition	   area,	   to	  include	  a	  social	  and	  human	  sciences	  chapter	  in	  its	  activities.	  Secondly,	   the	   knowledge-­‐related	   activities	   undertaken	   by	   patients’	   organizations	  profoundly	   transform	   the	   qualification	   of	   rare	   diseases	   and	   open	   discussion	   on	   their	  classification.	  To	  take	  but	  one	  example,	  Generation	  22,	  concerned	  with	  the	  22q11	  deletion	  syndrome,	   a	   complex	   syndrome	   involving	   heterogeneous	   disorders	   with	   multiple	  manifestations,	   has	   actively	   contributed	   to	   clarifying	   the	   clinical	   profiles	   of	   affected	  patients.	   In	   particular,	   drawing	   on	   families’	   observations,	   it	   pinned	   down	   the	   high	  prevalence	  of	  schizophrenia	  in	  these	  patients	  compared	  to	  the	  general	  population.	  While	  French	   specialists	   have	   long	   been	   reluctant	   to	   consider	   the	   extending	   range	   of	  manifestations	   and	   co-­‐morbidities	   of	   this	   syndrome,	  Génération	   22	   has	   recently	   secured	  collaboration	  with	  a	  psychiatrics	  genetics	  team	  in	  Switzerland	  with	  an	  aim	  to	  explore	  the	  psychiatric	   disorders	   that	   accompany	   the	   22q11	   DS.	   Moreover,	   the	   association	   now	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suspects	   that	   this	   syndrome	   may	   be	   less	   rare	   than	   previously	   estimated,	   for	   certain	  persons	   with	   schizophrenia	   may	   carry	   the	   deletion.	   By	   entering	   into	   the	   black	   box	   of	  complex	   biological	   pathways	   and	   entities	   that	   are	   still	   to	   be	   explored,	   Génération	   22	  contributes,	   as	   much	   as	   similar	   organizations	   do	   (Navon	   &	   Shwed,	   2012),	   in	   the	  emergence	   of	   an	   ad	   hoc	   disease	   category	   gathering	   “developmental	   disorders	   and	  deformity	  syndromes”,	  as	  French	  specialists	  provisionally	  term	  it.	  
FIGHTING	  REDUCTIONNISM:	  THE	  POLITICS	  OF	  KNOWLEDGE	  OF	  AN	  ADHD	  GROUP	  Parents	  of	  children	  with	  ADHD	  often	  start	   to	  mobilize	   for	   fighting	   the	   lack	  of	  medical	  recognition	  of	  this	  disorder,	  and	  the	  stigmatization	  of	  children	  as	  “brats”,	  notably	  because	  of	  parents’/mothers’	  supposedly	  bad	  parenting.	  Indeed,	  ADHD	  has	  long	  been,	  and	  still	  is	  a	  contested	   condition.	   Neurobiologists,	   child	   psychiatrists	   and	   psychologists,	   to	   cite	   but	   a	  few	   specialties,	   hold	   different	   views	   on	   the	   causes	   and	   manifestations	   of	   this	   disorder	  (Rafalovich,	   2001).	   In	   France,	   certain	   child	   psychiatrists,	   with	   a	   psychodynamics	  background,	   even	   deny	   the	   existence	   of	   ADHD,	   arguing	   that	   it	   may	   “hidden”	   child	   or	  adolescent	  depression,	  or	  even	  epitomize	  “normal”	  child	  or	  adolescent	  evolution.	  Some	  of	  them	  worry	   about	   “over-­‐diagnosis”	   of	   ADHD,	  which,	   from	   their	   point	   of	   view,	   are	   often	  “misdiagnosis”	   (Garcin,	   2011).	   Social	   scientists	   have	   highlighted	   how	   biomedical	  practitioners,	   the	   pharmaceutical	   industry	   and	   parent’s	   groups	   have	   promoted	   a	  biomedical	  framing	  of	  the	  disorder	  for	  attesting	  its	  “reality”	  against	  the	  prevarications	  of	  certain	  credentialed	  experts.	  Two	  phenomena	  are	  said	  to	  support	  this	  biomedicalization	  of	  ADHD:	  brain	  images	  which	  trace	  the	  dysfunction	  of	  certain	  neurotransmitters	  in	  children	  with	   ADHD,	   and	   the	   efficiency	   of	   certain	   medications,	   namely	   Ritalin©,	   on	   inattentive	  and/or	  hyperactive	  children.	  This	  biomedicalization	  of	  ADHD	  raises	  concerns	  on	  the	  risk	  of	   social	   normalization	   and	   control	   over	   behaviors	   considered	   as	   non-­‐desirable	   in	  performance-­‐oriented	  societies	  (Conrad,	  2007).	  	  HyperSupers,	  the	  French	  parents’	  group	  on	  ADHD	  created	  in	  2002	  after	  the	  launching	  of	   an	   electronic	   discussion	   list,	   soon	   realized	   that	   biomedicalization	   is	   not	   the	   one	   best	  way	   for	   understanding	   the	   disorder	   and	   caring	   for	   their	   children.	   Though	   the	   group	  manifests	   its	   interest	   in	   the	   neurodevelopmental	   make-­‐up	   of	   ADHD,	   as	   attested	   by	   a	  conference	  it	  organized	  on	  this	  topic	  following	  its	  2010	  general	  assembly	  of	  families,	  and	  is	  happy	  with	  the	  development	  of	  drugs,	  it	  tirelessly	  questions	  what	  exactly	  ADHD	  is,	  and	  how	   to	   address	   the	  multifaceted	  problems	   it	   induces	   for	   the	   children	   and	   their	   parents.	  Drawing	   on	   parents’	   testimonies,	   which	   point	   to	   the	   complex,	   variable	   and	   evolving	  manifestations	   of	   the	   disorder,	   HyperSupers	   steps	   back	   from	   any	   simple	   causal	  interpretation	  of	  the	  condition.	  Not	  only	  does	  it	  put	  forward	  the	  multi-­‐factorial	  nature	  of	  ADHD,	  it	  also	  casts	  doubt	  on	  the	  fact	  that	  the	  causes	  and	  consequences	  of	  the	  disorder	  can	  be	   easily	   sorted	   out.	   The	   president	   of	   HyperSupers	  whom	  we	   interviewed	   a	   number	   of	  times	   insisted	   that	   neurodevelopmental,	   social	   and	   psychological	   aspects	   of	   ADHD	   are	  interwoven	   and	   impact	   on	   each	   other.	   From	   the	   outset,	   this	   politics	   of	   illness	   has	   come	  hand	   in	  hand	  with	  the	  group’s	   intensive	  efforts	   in	  collecting	  and	  articulating	  a	  variety	  of	  bodies	   of	   academic	   knowledge	  with	   an	   aim	   to	   open	   discussion	   on	   the	   bio-­‐psycho-­‐social	  framing	  of	  the	  disorder.	  HyperSupers’	   eclecticism	   and	   openness	   recently	   translated	   in	   its	   launching	   of	   the	  
Journée	   Ribot-­‐Dugas,	   a	   one-­‐day	   annual	   scientific	   symposium	   named	   after	   two	   French	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psychologists.	  What	   is	   remarkable	  with	   this	   Journée	   is	   that	   despite	   the	   reluctance	   of	   its	  scientific	   committee,	  HyperSupers	  has	  managed	   to	  gather	   specialists	   from	  very	  different	  backgrounds	   who	   are	   not	   used	   to	   dialogue	   with	   each	   other:	   neurobiology,	   cognitive	  sciences,	   education	   sciences,	   child	   psychiatry,	   psychology,	   pharmacology,	   epidemiology,	  and	   even	   psychodynamics.	   Issues	   as	   diverse	   as	   the	   neurological	  mechanisms	   implied	   in	  ADHD,	  the	  sleep	  disorders	  that	  sometimes	  occur,	  and	  even	  the	  role	  of	  Omega	  3	  fatty	  acids	  in	   alleviating	   certain	   “symptoms”,	   have	   been	   put	   on	   the	   scientific	   agenda.	   Rather	   than	  taking	  the	  side	  of	  one	  or	  the	  other	  scientific	  community,	  the	  design	  of	  the	  Journée	  allows	  HyperSupers	   to	   shed	   light	   on	   the	   complexity	   and	   uncertainty	   of	   competing	   scientific	  understandings	   of	   ADHD.	   For	   the	   association,	   this	   does	   not	   mean	   that	   anything	   goes	  however:	   in	   this	   and	   other	   occasions,	   the	   president	   of	   HyperSupers	   regularly	   calls	   for	  further	   clarification	   of	   the	   hypothesis	   and	   methodologies	   that	   underlie	   the	   research	  projects	   undertaken	   by	   different	   scientific	   communities.	   HyperSupers’	   epistemic	   efforts	  have	  two	  main	  effects	  on	  the	  politics	  of	  knowledge	  in	  this	  condition	  area.	  Firstly,	   confronting	  diverse	   scientific	   communities,	  which	  more	   often	   than	  not	   turn	   a	  deaf	  year	  to	  each	  other,	  HyperSupers	  clearly	   intends	  to	  give	  shape	  to	  a	  multidisciplinary	  network	   of	   expertise	   and	   issues	   on	   ADHD.	   Though	   the	   association	   has	   historically	  established	   tight	   bonds	   with	   a	   few	   specialists	   who	   are	   sympathetic	   to	   its	   cause,	   it	  nevertheless	   strives	   to	   expand	   the	   bodies	   of	   knowledge	   it	   deems	   relevant	   to	   assemble	  around	   families’	   experiences.	   It	   is	   too	   soon	   to	   tell	   whether	   this	   will	   renew	   research	  policies	   on	   ADHD,	   but	   one	   can	   fairly	   assume	   that	   the	   association	   is	   playing	   a	   crucial	  mediating	  role	  in	  the	  development	  of	  multidisciplinary	  approaches	  in	  this	  condition	  area.	  HyperSupers’	   numerous	   publications	   provide	   evidence	   of	   the	   association	   “shopping	  around”	  with	   concerned	   people’s	   experiences	   as	   its	   compass.	   	   For	   example,	   the	   “Token	  economy	  method”	   it	   posted	   a	   few	   years	   ago	   on	   its	  website,	   advising	   parents	   to	   reward	  their	  children	  when	  they	  are	  doing	  well,	  and	  to	  draw	  their	  attention	  to	  alternative	  small	  tasks	   when	   they	   are	   “going	   into	   a	   spin”,	   was	   simultaneously	   nurtured	   by	   parents’	  experiences	  and	  by	  psychological	   theories	  which	   show	   that	   children	  with	  ADHD	   tend	   to	  loose	   self-­‐esteem	   because	   of	   the	   constant	   denigration	   of	   their	   behaviors.	   This	   does	   not	  prevent	   parents	   from	   considering	   other	   “solutions”	   to	   other	   problems	   posed	   by	   ADHD,	  such	  as	  neurofeedback	  for	  instance,	  a	  type	  of	  biofeedback	  which	  focuses	  on	  the	  brain	  and	  central	   nervous	   system:	   by	   placing	   sensors	   on	   a	   person’s	   head,	   it	   provides	   a	   display	   of	  brain	   activity,	   or	   “brainwaves”	   that	   can	   be	   monitored	   and	   retrained.	   Though	  neurofeedback	  it	   is	  not	  necessarily	  perceived	  as	  an	  evidence-­‐based	  therapy	  by	  the	  wider	  medical	  community,	  and	  is	  much	  discussed	  within	  the	  association,	  it	  surfaces	  as	  one	  body	  of	  knowledge	  and	  practices	  at	  which	  the	  association	  is	  taking	  a	  close	  look.	  Secondly,	  one	  major	  consequence	  that	  HyperSupers	  expects	   from	  its	  epistemic	  efforts	  is	  the	  shaping	  of	  what	  it	  calls	  a	  “multimodal	  cure	  and	  care	  strategy”.	  As	  suggested	  by	  the	  examples	   mentioned	   above,	   HyperSupers	   claims	   for	   the	   assemblage	   of	   medications,	  parenting	   therapies,	   educational	   methods,	   and	   even	   psychotherapies,	   adjusted	   to	   each	  child’	   situation	   and	   its	   evolution.	   Such	   a	   strategy	   not	   only	   translates	   the	   association’s	  politics	  of	  illness;	  it	  also	  enacts	  its	  politics	  of	  knowledge	  insofar	  as	  it	  implies	  a	  continuing	  exploration	   and	   weighting	   up	   of	   the	   evidence	   basis	   of	   various	   cure	   and	   care	   practices.	  Thus,	   politics	   of	   illness,	   politics	   of	   knowledge	   and	   politics	   of	   care	   together	   constitute	   a	  
8	  	  
threefold	   action	   towards	   the	   recognition	  of	  ADHD	  as	   a	   complex	  disorder	   that	   cannot	  be	  reduced	  either	  to	  the	  biological,	  to	  the	  social,	  or	  to	  the	  psychological	  only.	  
RAISING	  ISSUES	  AND	  UNPACKING	  EVIDENCE:	  THE	  KNOWLEDGE	  POLITICS	  OF	  A	  CHILDBIRTH	  GROUP	  Childbirth	   activism	   displays	   a	   configuration	   which	   contrasts	   with	   the	   conditions	   we	  analyzed,	  as	  it	  has	  often	  been	  described	  as	  a	  de-­‐medicalization	  movement:	  drawing	  upon	  a	  survey	  of	  19	  organizations	  in	  England,	  the	  Netherlands	  and	  Germany,	  Tyler	  (2002)	  points	  to	   the	   existence	   of	   shared	   views	   on	   pregnancy	   and	   childbirth	   seen	   as	   “natural	  physiological	  life	  events	  that	  should	  be	  as	  free	  as	  possible	  from	  medical	  intervention”	  and	  on	   “the	   routine	   application	   of	   medical	   technology	   [experienced]	   as	   disempowering”	   (p.	  139).	  More	  recently,	  other	  works	  stressed	  the	  emergence	  of	  a	  rhetoric	  of	   “choice”	  which	  should	   extend	   to	   the	   right	   to	   choose	   elective	   cesarean	   section	   (Beckett,	   2005).	  Much	   of	  academic	   discussion	   revolves	   around	   the	   relationships	   between	   these	   movements	   and	  various	   waves	   of	   feminisms	   (Annandale	   &	   Clark,	   1996;	   Reiger,	   1999,	   2000):	   for	   some,	  technology	   supports	   the	   obstetricians’	   control	   over	   women’s	   body	   and	   is	   seen	   as	  alienating	   (Katz	   Rothman,	   1982;	   Murphy-­‐Lawless,	   1998;	   Halfon,	   2010);	   for	   others,	  technology	   can	   contribute	   to	   women’s	   empowerment	   by	   freeing	   them	   from	   biological	  determinism.	  Standard	  medical	  practices	  appear	  as	  an	  external	   factors	  which	  obey	   their	  own	  logic:	  depending	  on	  their	  perspective,	  women	  demand	  the	  possibility	  to	  opt	  in	  or	  opt	  out.	  Recent	  works	  have	   criticized	   this	   view	  by	   stressing	   that	   the	  way	  women	   can	   frame	  their	   choices	   is	   highly	   dependent	   on	   obstetrics	   itself,	   on	   its	   organization	   and	   on	   the	  knowledge	   it	  mobilizes	   to	   define	   appropriate	   practices	   (Crossley,	   2007;	  Donovan,	   2006;	  Spoel,	  2007).	  Our	  observations	  in	  four	  European	  countries	  (Akrich	  et	  al.,	  2012)	  led	  to	  the	  conclusion	  that	  childbirth	  organizations	  have	  been	  indeed	  taking	  this	  criticism	  as	  a	  point	  of	   departure	   for	   their	   activism:	   one	   should	   argue	   that,	   at	   least	   for	   the	   last	   decade,	   they	  have	  tried	  to	  transform	  obstetrics	  from	  within,	  and	  that,	  to	  do	  so,	  they	  have	  drawn	  upon	  an	   extensive	   knowledge	   work	   seeking	   the	   integration	   of	   women’s	   experiences	   as	   a	  challenging	   or	   complementing	   source	   of	   obstetric	   knowledge.	  Drawing	   upon	   the	   French	  case	   in	   the	   following	   section,	   we	   describe	   this	   knowledge	  work	   and	   its	   implications	   on	  both	  research	  policy	  and	  health	  policy.	  Created	   in	   2003,	   the	   Collectif	   interassociatif	   autour	   de	   la	   naissance	   (CIANE)	   gathers	  about	  40	  French	  childbirth	  organizations:	  local	  support	  groups	  and	  national	  organizations	  focusing	   on	   specific	   issues	   (cesarean	   section,	   homebirth,	   post-­‐partum	   depression	   etc.),	  some	  of	  these	  having	  emerged	  in	  the	  early	  2000s	  from	  internet	  discussion	  groups	  which	  developed	  a	  scientific	  expertise	  and	  a	  culture	  of	  discussion	  articulating	  this	  expertise	  with	  personal	  experiences	  (Akrich,	  2010)	  which	  has	  been	  crucial	  in	  the	  development	  of	  CIANE.	  The	   CIANE	   involvement	   into	   knowledge	   activities	   takes	   three	   forms	   that	   we	   examine	  below.	  Firstly,	   they	  question	  current	  medical	  practices	   in	   the	   light	  of	  an	  analysis	  of	  scientific	  literature,	  and,	  amongst	  other	  actions,	  make	  it	  politically	  operative	  by	  participating	  in	  the	  elaboration	  of	   clinical	   guidelines	  organized	  by	   the	  HAS	   (High	  Authority	  of	  Health).	  They	  even	  took	  part	  in	  the	  determination	  of	  its	  work	  program	  by	  sending	  referrals	  on	  the	  issues	  they	  deem	  relevant.	  Drawing	  on	  its	  scientific	  expertise,	  the	  CIANE	  has	  thus	  provoked	  and	  participated	   in	   the	   elaboration	   of	   guidelines	   on	   topics	   such	   as	   induction,	   episiotomy,	  fundal	  pressure,	   indications	   for	  planned	  cesarean	  sections:	   the	  choice	  of	   the	   topics	   to	  be	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tackled	  was	  linked	  to	  the	  informal	  knowledge	  that	  they	  gathered	  on	  women’s	  experiences	  and	  especially	  on	  situations	  where	  women	  were	  confronted	  with	  professionals’	  decisions	  that	   they	   eventually	   found	   detrimental	   and	   possibly	  made	   on	   disputable	   grounds.	   To	   a	  certain	   extent,	   the	   CIANE	   approach	   can	   be	   understood	   as	   a	  way	   of	   re-­‐opening	   all	   these	  individual	   failed	  debates	  between	  professionals	  and	  women:	   thus,	   the	  aim	   is	   to	   set	  up	  a	  space	  for	  negotiation	  where	  expectations	  of	  both	  parties	  can	  be	  framed	  in	  a	  stabilized	  and	  public	  way.	  Secondly,	  they	  question	  the	  relevance	  of	  medical	  practices,	  authoritative	  discourse	  and	  credentialed	   knowledge	   from	   the	   perspectives	   opened	   by	   experiential	   knowledge:	   this	  strategy	   is	   not	   exclusive	   from	   the	   previous	   one	   as	   is	   illustrated	   by	   the	   critical	   analysis	  produced	   by	   the	   CIANE	   very	   early	   in	   its	   existence	   about	   guidelines	   on	   episiotomy	  produced	   by	   the	   College	   of	   Obstetricians.	   This	   analysis	   was	   elaborated	   drawing	   upon	  existing	  internet	  discussion	  groups:	  the	  groups	  called	  for	  testimonies,	  confronted	  them	  to	  the	  academic	  literature,	  and	  pointed	  to	  several	  complications	  of	  episiotomy	  that	  have	  been	  neglected	   both	   by	   the	   literature	   and	   the	   guidelines	   but	   have	   severe	   consequences	   in	  women’s	   everyday	   life;	   it	   ended	  up	   by	   reframing	   the	   problem	  not	   as	   “the	   prevention	   of	  episiotomy”,	   expression	   that	   naturalizes	   the	   intervention,	   but	   as	   “the	   prevention	   of	  perineal	  lacerations”,	  which	  opens	  up	  a	  whole	  set	  of	  other	  policy	  options.	  Amongst	  these	  options,	   acting	   upon	   positions	   during	   labor	   seem	   relevant	   but	   the	   CIANE	   pointed	   to	  another	   difficulty,	   the	   oversimplification	   associated	   with	   experimental	   protocols	   of	  research	  which	   excludes	   gathering	   data	   on	   situations	  where	  women	   are	   free	   to	   choose	  their	  position.	  The	  de-­‐medicalization	  vocabulary	   is	   indeed	  useless	   to	  describe	  what	   is	  at	  stake	  here:	  the	  mobilization	  and	  production	  of	  experiential	  knowledge	  allowed	  the	  group	  to	  deconstruct	  both	  the	  framing	  of	  the	  issue	  and	  the	  legitimacy	  of	  credentialed	  knowledge;	  it	   led	  to	  propositions	  for	  amending	  the	  guidelines	  but	  also	  raised	  some	  issues	  as	  regards	  medical	  research,	  thus	  trying	  to	  influence	  both	  health	  policy	  and	  research	  policy.	  	  Thirdly,	  they	  put	  together	  existing	  but	  separated	  pieces	  of	  knowledge	  in	  an	  attempt	  to	  reframe	   issues	   at	   stake:	   it	  might	   result	   in	   a	   questioning	   of	   research	   policy	   as	  well	   as	   of	  health	  policy	  as	  can	  be	  seen	  in	  the	  following	  examples.	  In	  2004,	  the	  CIANE	  asked	  to	  review	  clinical	  guidelines	  on	  the	  prevention	  of	  post	  partum	  hemorrhage	  (PPH)	  which	  appears	  to	  be	  involved	  into	  more	  than	  half	  maternal	  deaths.	  Again,	  they	  contested	  the	  use	  of	  the	  word	  “prevention”,	  as	  the	  guidelines	  did	  not	  even	  mention	  the	  issue	  of	  what	  may	  cause	  PPH,	  to	  the	   exception	   of	   well-­‐known	   risk	   factors	   that	   do	   not	   represent	   the	   majority	   of	   severe	  cases.	  The	  CIANE	  put	   together	   firstly,	   the	   fact	   that	   in	  France,	   the	  prevalence	  of	  HPP	  was	  higher	   than	   in	   other	   countries,	   and,	   secondly,	   that	   some	   scarce	   publications,	   including	  publications	   by	  midwives,	   formulate	   hypothesis	   about	   the	   role	   of	  medical	   practices	   and	  the	  administration	  of	  oxytocin	  during	   labor	   in	   the	  occurrence	  of	  PPH:	   as	   this	  practice	   is	  more	   frequent	   in	   France	   than	   in	   most	   countries,	   it	   is	   tantalizing	   to	   infer	   a	   correlation	  between	   the	   two	   facts.	   After	   months	   of	   efforts,	   they	   succeeded	   in	   convincing	   an	  administration	  to	  fund	  a	  research	  project	  which	  resulted	  in	  a	  first	  publication	  in	  2011	  in	  the	   BMJ	   confirming	   the	   existence	   of	   a	   link	   between	   the	   administration	   of	   oxytocin	   and	  PPH.	  Whereas,	   in	  this	  case,	  the	  different	  pieces	  of	  knowledge	  were	  all	  medical,	   in	  a	  more	  recent	   case,	   the	   knowledge	   they	   put	   together	   were	   much	   more	   heterogeneous:	   they	  elaborated	   a	   document	   developing	   a	   new	   approach	   as	   regards	   health	   professional	  insurance.	   Due	   to	   European	   legislation,	   midwives	   attending	   homebirths	   need	   to	   get	   a	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professional	   insurance.	   In	   France,	   insurers	   take	   as	   a	   reference	   the	   insurance	   premium	  paid	  by	  obstetricians,	   amount	  which	   is	  not	   affordable	   for	  midwives.	  The	  CIANE	  analysis	  consists	   of	   a	   large	   diagram	  making	   visible	   the	   different	   kinds	   of	   risks,	   some	   specific	   to	  hospitals,	  some	  specific	  to	  homebirths,	  others	  common	  to	  both	  situations;	  the	  diagram	  is	  accompanied	   by	   a	   detailed	   argumentation	   based	   on	   medical	   knowledge	   but	   also	   on	  psychological	  knowledge	  or	  legal	  one,	  as	  the	  risk	  at	  stake	  is	  a	  litigation	  risk	  which	  does	  not	  confuse	  with	   a	  medical	   risk	   and	   depends	   upon	   varied	   factors.	   This	   document	   has	   been	  endorsed	  by	  the	  National	  College	  of	  Midwives	  and	  three	  midwives’	  unions.	   It	  aims	  at	  re-­‐opening	   the	   debate	   about	   premiums’	   calculation,	   which	   has	   been	   closed	   unilaterally	   by	  insurers,	  not	  providing	  the	  calculation	  key	  but	  trying	  to	  demonstrate	  that	  the	  current	  one	  is	  neither	  adequate	  nor	  fair.	  	  In	  all	  these	  actions,	  the	  CIANE	  does	  not	  appear	  as	  driven	  by	  a	  normative	  perspective,	  it	  does	  not	  claim	  for	  rights,	  it	  tries	  to	  build	  a	  users’	  perspective	  on	  obstetrics,	  its	  practices,	  its	  organization,	  borrowing	  the	  obstetric	   language	   itself:	  by	  doing	  so,	   it	  opens	  up	  a	  space	  of	  discussion	  and	  negotiation	  with	  other	  stakeholders.	  
SHAPING	  THE	  CONCERNED	  PUBLICS:	  SOCIAL	  ENQUIRY	  IN	  AN	  ALZHEIMER	  DISEASE	  ORGANIZATION	  Emerging	   in	   the	   late	   1970s	   and	   early	   1980s,	   European	  Alzheimer’s	   Disease	   patients’	  organizations	   resembled	   in	   many	   respects	   those	   in	   the	   US	   from	   where	   they	   were	  isomorphically	   imported.	   In	   both	   contexts,	   the	   cause	   around	  which	   Alzheimer’s	   disease	  patients’	  organizations	  were	  initially	  mobilized	  was	  to	  provide	  support	  to	  carers	  of	  people	  diagnosed	   with	   the	   disease,	   not	   patients	   themselves	   who	   were	   deemed	   to	   have	  experienced	  a	  “loss	  of	  self”	  and	  thus	  to	  be	  liminal	  or	  non-­‐persons	  (O’Donovan,	  Moreira	  and	  Howlett,	   in	  press).	  However,	  a	  significant	  difference	  between	  the	  early	  US	  and	  European	  Alzheimer’s	   disease	   patients’	   organizations	   was	   their	   knowledge-­‐related	   activities.	   The	  prioritization	  of	  proactive	  engagement	   in	  biomedical	  knowledge	  production	   in	   the	  quest	  for	  a	  cure	  that	  was	  a	  defining	  feature	  of	  US	  patients’	  organizations,	  as	  described	  by	  Patrick	  Fox	   (1989),	  was	   not	   replicated	   by	   the	   European	   organizations,	   including	   the	   Alzheimer	  Society	  of	   Ireland.	  Established	   in	  1982,	   the	  Alzheimer	  Society	  of	   Ireland	  was	   the	   second	  Alzheimer’s	  disease	  patients’	  organizations	  to	  emerge	  in	  Europe,	  and	  similar	  to	  its	  British	  counterpart	   established	   three	   years	   previously,	   its	   chief	   preoccupation	   was	   service	  delivery.	  The	  organization	  has	  since	  become	  one	  of	  the	  largest	  service	  provision	  charities	  in	  Ireland;	  in	  2011,	  86	  per	  cent	  of	  its	  €17	  million	  budget,	  most	  of	  which	  came	  from	  State	  grants,	   was	   spent	   on	   service	   delivery	   (Alzheimer	   Society	   of	   Ireland,	   2012).	  Notwithstanding	  this	  prioritization	  of	  service	  provision,	  the	  Alzheimer	  Society	  of	  Ireland	  is	  now	  also	  engaged	  in	  intensive	  epistemic	  work	  producing	  and	  circulating	  facts	  and	  figures	  about	   dementia	   and	   its	   care,	   much	   of	   which	   is	   motivated	   by	   efforts	   to	   establish	   the	  condition	  as	  a	  national	  and	  European	  public	  health	  priority.	  The	  Dementia	  Manifesto	  2007	  
–	  2009,	   the	  “cornerstone	  of	  the	  Society’s	  political	   lobbying	  campaign”	  (Alzheimer	  Society	  of	   Ireland,	  2007)	   serves	  as	  one	  example;	   it	  was	  a	   synthesis	  of	  knowledge	  about	  priority	  issues	   for	   people	   with	   dementia	   and	   their	   carers	   generated	   by	   a	   National	   Consumer	  Summit,	  consultation	  with	  “stakeholders”	  and	  the	  commissioning	  of	  a	  position	  paper	  by	  a	  health	   economist.	   The	   organization	   is	   enmeshed	   in	   networks	   of	   biomedical	   expertise,	  including	  those	  at	  European	  level	  through	  its	  strong	  links	  with	  the	  European	  coalition	  of	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POs	  Alzheimer	  Europe,	  but	  engagement	   in	  biomedical	   research	   is	   just	  one	   feature	  of	   the	  organization’s	  varied	  repertoire	  of	  knowledge-­‐related	  activities.	  	  Social	   research	   has	   featured	   prominently	   in	   the	   history	   of	   the	   Alzheimer	   Society	   of	  Ireland’s	  epistemic	  work.	  Motives	  for	  considering	  this	  species	  of	  knowledge	  have	  included	  encoding	  and	   formalizing	   the	  experiential	  knowledge	  of	   carers	  and	   the	   “costs	  of	   caring”.	  However,	   in	   recent	   years,	   moves	   to	   redefine	   Alzheimer’s	   disease	   patienthood	   and	  recognize	   the	   fully-­‐fledged	   personhood	   of	   those	   diagnosed	   with	   the	   disease	   have	  presented	   the	   organization	   with	   profound	   epistemic	   challenges;	   it	   relies	   upon	   social	  research	   to	   represent	   patients’	   experiential	   knowledge	   and	   perspectives,	   but	   is	  simultaneously	  confronted	  with	  the	  limitations	  of	  those	  very	  social	  science	  techniques	  and	  with	   the	   need	   to	   innovate	   methodologically.	   These	   epistemic	   challenges	   are	   intimately	  connected	  with	  the	  political	  challenge	  of	  social	  enfranchisement	  of	  people	  with	  dementia	  within	   the	   organization.	   To	   understand	   the	   distinctive	   features	   and	   challenges	   of	   this	  Alzheimer’s	  Disease	  evidence-­‐based	  activism	   it	   is	   important	   to	  appreciate	   the	  significant	  and	  hybridizing	  shift	  that	  has	  taken	  place	  in	  the	  “cause	  regime”	  of	  the	  organization,	  which	  has	   included	   an	   expansion	   of	   the	   constituency	   the	   organization	   claims	   to	   represent	   to	  include	  both	  carers	  and	  patients.	  Similar	  to	  Alzheimer’s	  disease	  	  organizations	  elsewhere,	  the	  Alzheimer’s	  Society	  of	   Ireland	  has	  been	  transformed	  from	  a	  carers’	  organization	  to	  a	  carers’	  and	  patients’	  organization.	  	  The	   organization	   has	   made	   the	   “turn	   to	   personhood”	   that	   problematizes	   knowledge	  about	   the	   disease	   that	   understands	   it	   as	   inducing	   a	   “loss	   of	   self”	   form	   of	   patienthood,	  knowledge	   that	   it	   and	   other	   organizations	   in	   the	   international	   Alzheimer’s	   disease	  movement	  played	  a	  crucial	  role	  in	  co-­‐producing	  and	  circulating	  (Beard,	  2004).	  Much	  of	  the	  scholarship	  on	  what	  Nancy	  Scheper-­‐Hughes	  and	  Margaret	  Lock	  (1986:	  137)	  referred	  to	  as	  Alzheimer’s	   disease’s	   metaphoric	   “double”,	   “the	   layers	   of	   stigma,	   rejection,	   fear	   and	  exclusion”	  attached	  to	  the	  disease,	  attributes	  blame	  primarily	  to	  its	  biomedical	  framing	  as	  a	  disease	   that	  gradually	  destroys	   the	  patient’s	  brain	  and	  consequently	   their	  personhood	  (Kitwood,	   1997;	   Basting,	   2003).	   But	   equally,	   the	  more	   recent	   understanding	   of	   what	   it	  means	  to	  be	  diagnosed	  with	  dementia	  that	  recognizes	  the	  personhood	  of	  the	  patient	  tends	  to	   be	   attributed	   to	   the	   Alzheimer’s	   disease	   biomedical	   enterprise’s	   investments	   in	   new	  devices	   for	   early	   diagnosis	   and	   treatments	   aimed	   at	   delaying	   the	   progression	   of	   the	  disease	  (Moreira,	  2009).	  The	  Alzheimer	  Society	  of	  Ireland’s	  research	  on	  telecare	  provides	  an	  illustration	  of	  how	  the	   organization	   has	   co-­‐produced	   and	   subsequently	   problematized	   the	   “loss	   of	   self”	  patient	   identity	  and	  confronted	   the	  epistemic	  challenge	  of	   representing	   the	  perspectives	  of	  people	  with	  dementia.	  In	  2007,	  the	  organization	  instigated	  a	  pilot	  project	  of	  telecare	  as	  a	   technology	   of	   independent	   living.	   The	   research	   evaluating	   the	   project	   framed	   carers	  rather	   than	   people	   with	   dementia	   as	   the	   users	   of	   the	   telecare	   technologies	   and	   as	   the	  actors	  whose	  perspectives	  the	  research	  sought	  to	  ascertain.	  The	  social	  disenfranchisement	  of	  people	  with	  dementia	  through	  their	  exclusion	  from	  direct	  participation	  in	  the	  evaluative	  study	  was	  compounded	  by	  the	  exclusion	  of	  many	  of	  them	  from	  the	  decision	  to	  participate	  in	   the	   pilot	   project	   and	   the	   installation	   of	   the	   telecare	   devices	   (Alzheimer	   Society	   of	  Ireland,	  2010).	  A	  subsequent	  telecare	  project,	  the	  EU-­‐funded	  INDEPENDENT	  -­‐	  ICT	  Enabled	  Service	  Integration	  for	  Independent	  Living,	  is	  adopting	  a	  very	  different	  style	  of	  research	  by	  including	   people	   with	   dementia	   as	   research	   participants,	   rather	   than	   relying	   on	   their	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carers	   as	   proxies.	   Explaining	   the	   intention	   to	   use	   the	   technique	   of	   ethnographic	  interviewing	  to	  generate	  knowledge	  of	  patients’	  experiences	  of	   the	   impact	  of	   telecare	  on	  their	  quality	  of	  life,	  a	  researcher	  involved	  in	  the	  project	  explained:	  We	  will	  be	  doing	  a	  detailed	  assessment	  of	  the	  quality	  of	  life	  with	  people	  with	  dementia.	  Hopefully,	   we’ll	   be	   working	   with	   them	   directly	   to	   understand	   their	   view	   of	   ...what	   is	  important	   in	  quality	  of	   life	   for	   them	  and	  how	  telecare	  might	   impact	   that.	  Now	  obviously	  we	   can	   do	   that	   with	   people	   with	   mild	   to	   moderate	   dementia.	   We	   have	   to	   work	   really	  carefully	  with	   people	  who	   are	   further	   on	   in	   the	   disease	   to	   see	  what	   is	   the	   best	   way	   of	  communicating	  with	  them	  to	  get	  this	  information.	  (Delaney,	  2010)	  	  	  Here	  we	  can	  see	  that	  social	  science	  techniques	  are	  not	  a	  given	  but	  are	  to	  be	  explored	  as	  potential	   voicing	   devices	   that	   can	   make	   the	   experiential	   knowledge	   of	   people	   with	  dementia	  visible	  and	  meaningful.	  As	  we	  have	  discussed	  in	  more	  detail	  elsewhere	  (Moreira,	  O’Donovan	  and	  Howlett,	  in	  press),	  the	  technique	  of	  the	  interview	  is	  embedded	  in	  a	  politics	  of	  subjectivity	  that	  views	  individuals	  as	  knowledgeable	  agents	  in	  their	  own	  social	  worlds.	  Such	  presuppositions	  may	  require	  revisiting	  the	  methodological	  innovations	  being	  crafted	  in	  this	  second	  telecare	  project	  of	  the	  Alzheimer	  Society	  of	  Ireland.	  	  
CONCLUSION	  Through	  the	  variety	  of	  cases	  we	  presented,	  we	  intended	  to	  demonstrate	  that	  patients’	  and	   activists’	   involvement	   in	   knowledge	   activities	   is	   not	   restricted	   to	   a	   limited	   set	   of	  diseases	  (e.g.	  those	  for	  which	  biomedical	  research	  is	  considered	  as	  a	  priority),	  but	  extends	  to	  all	  kinds	  of	  conditions,	  including	  those	  which	  still	  remain	  contested.	  This	  involvement	  in	  knowledge	  stands	  at	  the	  core	  of	  patients’	  organizations’	  activities,	  and	   that	   is	   what	   we	   try	   to	   capture	   through	   the	   expression	   “evidence-­‐based	   activism”.	  Firstly,	   this	  expression	  sheds	   light	  on	  how	  patients’	  organizations	  define	  the	  causes	  they	  engage	   in:	   even	   if	   patients’	   organizations	   constitute	   around	   a	   shared	   condition	   or	  experience,	   this	   does	   not	   necessarily	   imply	   a	   straightforward	   definition	   of	   their	   claims.	  Sometimes,	   as	   illustrated	   by	   the	   case	   of	   the	   French	   association	   on	   rare	   disabilities	   and	  diseases,	   what	   the	   “shared	   experience”	   consists	   of	   is	   not	   given	   once	   and	   for	   all	   but	  emerges	   and	   changes	   in	   the	   course	   of	   the	   on-­‐going	   transformation	   of	   people’s	   lives	   in	  which	   medicine	   itself	   plays	   a	   significant	   role.	   Thus,	   the	   transformation	   of	   individual	  complaints	   into	   collective	   claims	   involves	   the	   collective	   production	   of	   knowledge	   and	  analysis	   of	   individual	   situations	   and	   its	   articulation	   to	   the	   existing	   medical	   and	   care	  system:	   without	   the	   constitution	   of	   such	   expertise	   –	   which	   largely	   draws	   on,	   and	   even	  renews,	  as	  seen	  in	  the	  Alzheimer	  Disease	  case,	  social	  sciences	  techniques	  –	  POs	  would	  not	  be	  anything	  else	  than	  support	  groups.	  	  Secondly,	   this	   entanglement	   between	   knowledge	   work	   and	   political	   work	   is	   also	   at	  stake	   in	  the	  engagement	  of	  patients’	  organizations	   in	  medical	  research:	  as	  demonstrated	  in	   the	   case	  of	  22q11	  deletion	  and	   in	   the	  ADHD	  case,	   the	  active	  participation	  of	  patients’	  organizations	   to	   “research	  policy”,	   or	   at	   least	   to	   the	   formulation	  of	   research	   issues	   they	  deem	   relevant	   cannot	   be	   separated	   from	   their	   continuous	   effort	   to	   get	   a	   grip	   on	   their	  condition,	   i.e.	   to	   understand	  what	   it	   is,	   how	  and	  why	   it	   affects	   people’s	   lives,	  which	   can	  eventually	  lead	  to	  a	  drastic	  redefinition	  of	  diseases	  or	  the	  emergence	  of	  new	  nosographic	  categories.	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Thirdly,	  patients’	  organizations	  engagement	  in	  science	  and	  in	  knowledge	  production	  is	  a	   key	   element	   in	   the	   building	   of	   relationships,	   even	   confrontational,	   with	   a	   number	   of	  other	  actors,	  and	  especially	  professionals	  and	  researchers:	  being	  able	  to	  go	  back	  and	  forth	  between	  people’s	  experiences	  and	  medical	  knowledge	  opens	  new	  capacities	  of	  action	  for	  patients’	  organizations.	  As	  mentioned	  above,	  participating	  to	  the	  medical	  definition	  of	  the	  condition	  is	  one	  of	  these	  capacities	  as	  well	  as	  participating	  to	  the	  elaboration	  of	  guidelines,	  to	   the	   setting	   up	   of	   centers	   of	   reference,	   or	   to	   the	   definition	   of	   care	   pathways:	   more	  generally,	   this	   engagement	   with	   knowledge	   opens	   up	   new	   spaces	   for	   discussion	   and	  negotiation	  with	   involved	  actors	   and,	   in	   some	   cases,	   results	   in	   the	  building	  of	   epistemic	  communities.	  Does	   our	   analysis	   suggest	   a	   move	   towards	   institutionalization	   of	   patients’	  organizations	   that	   would	   hinder	   their	   contestation	   power	   and	   “normalize”	   them	   as	  ordinary	  players	  in	  a	  game	  ruled	  by	  official	  authorities?	  Are	  POs	  instrumentalized	  as	  civil	  society	  representatives	  that	  give	  legitimacy	  to	  decisions	  still	  massively	  in	  the	  hands	  of	  the	  “real	  experts”?	  In	  other	  words,	  do	  we	  face	  a	  fool’s	  game?	  On	   the	   one	   hand,	   one	   could	   say	   that	   patients’	   organizations	  who	   engage	   in	  what	  we	  called	  “evidence-­‐based	  activism”	  accept	  to	  use	  the	  language	  of	  “dominant”	  actors	  and	  that	  should	   be	   considered	   as	   a	   success	   for	   biomedicine	   and	   health	   professionals;	   there	   are	  probably	  some	  associated	  losses	  as	  the	  capacity	  to	  mobilize	  around	  more	  overtly	  political	  slogans	   centered	   around	   rights	   or	   as	   the	   fact	   that	   it	   tends	   to	   overcome	   issues	   such	   as	  social	   inequalities.	   On	   the	   other	   hand,	   we	   tried	   to	   demonstrate	   that	   it	   constitutes	   a	  powerful	   leverage	  which	   allows	  patients’	   organizations	   to	  penetrate	  others’	   territory,	   to	  redefine	   borders,	   to	   bring	   in	   new	   entities	   and	   new	   issues,	   so	   that	   the	  whole	   geography	  may	   be	   turned	   upside	   down	   in	   some	   cases.	   Research	   actions	   that	   some	   rare	   diseases	  organizations	   undertook	   were	   explicitly	   aimed	   at	   shaking	   the	   medical	   world	   which	  thought	  there	  was	  nothing	  to	  be	  done;	  pushing	  Alzheimer	  disease	  patients	  into	  the	  arena	  of	  discussion	  through	  the	  mediating	  tools	  of	  social	  research	   is	  not	  especially	   intended	  to	  please	   professionals	   nor	   policy	   makers;	   criticizing	   the	   way	   obstetricians	   frame	  interventions	   and	   questioning	   research	   methodology	   is	   generally	   perceived	   as	   rather	  aggressive	   by	   the	   professionals;	   forcing	   various	   disciplines	   to	   discuss	   about	   their	  understandings	  of	  ADHD	  is	  clearly	  to	  infringe	  what	  researchers	  and	  clinicians	  consider	  as	  their	   prerogatives.	   So,	   “evidence-­‐based	   activism”	   is	   not,	   in	   our	   view,	   a	   soft	   version	   of	  activism	  that	  would	  facilitate	  the	  instrumentalization	  of	  patients’	  organizations	  more	  than	  other	  forms	  of	  activism	  would	  do:	  on	  the	  contrary,	  it	  gives	  them	  quite	  effective	  munitions	  to	  contest	  both	  medical	  “paradigms”	  and	  the	  organization	  of	  care.	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